JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.
about
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@en
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@nl
type
label
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@en
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@nl
prefLabel
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@en
JAK2/IDH-mutant-driven myelopr ...... combined targeted inhibition.
@nl
P2093
P2860
P50
P356
P1476
JAK2/IDH-mutant-driven myelopr ...... o combined targeted inhibition
@en
P2093
Alan H Shih
Amritha Varshini Hanasoge Somasundara
Anna Sophia McKenney
April Chiu
Barbara Spitzer
Craig B Thompson
Efthymia Papalexi
Elizaveta Freinkman
Julie Teruya-Feldstein
P2860
P304
P356
10.1172/JCI94516
P407
P577
2018-01-22T00:00:00Z